Wesana Health logo

Wesana Health(OTC) WSNAF

Market Cap$73.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-100%
5 Year-100%
1 Year-74%
1 Month+0%
$0.00
+0.00%
+0.00Today
Wesana Health last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-28
Wesana Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-08-03
1 month+0%USD 0.002026-07-14
3 month+0%USD 0.002026-04-21
Year to date-65%USD 0.012025-12-31
1 year-74.07%USD 0.012025-08-28
3 year-91.75%USD 0.042023-08-29
5 year-99.86%USD 2.482021-08-27
Since inception-99.89%USD 3.102021-05-10

Wesana Health Financials at a Glance

Market Cap

$73.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$1.18M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-746.81 (Low)

Price

$0.00

Volume

200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.03

Estimated Earnings Date

Aug 28, 2026

WSNAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Wesana Health

Wesana Health Holdings Inc. is a life sciences firm focused on advancing psychedelic-based therapies, particularly psilocybin-enhanced psychotherapy. The company aims to address traumatic brain injuries (TBI) and related mental health conditions through scientifically validated compounds and therapeutic strategies.

Products and Services
  • Psychedelic-based therapies targeting TBI and mental health
  • Psilocybin-enhanced psychotherapy for trauma recovery
  • Research and development of innovative therapeutic strategies
Growth Outlook
  • Expanding interest in psychedelic therapies within the healthcare sector
  • Potential partnerships with research institutions for clinical trials
  • Increasing public awareness of mental health issues driving demand
Financial Highlights
  • Recent quarterly net income of -$36,666, indicating ongoing investment in R&D
  • Trailing twelve months (TTM) revenue of $0, reflecting early-stage development
  • Cash and short-term investments of $46,929 as of September 30, 2024
Wesana Health Holdings Inc. operates in a rapidly evolving sector, with a focus on innovative treatments for mental health and neurological conditions. The company's commitment to research and development positions it well to capitalize on the growing acceptance of psychedelic therapies. Despite current financial challenges, the potential for future growth remains significant, driven by increasing demand for effective mental health solutions. The company's strategic focus on partnerships and clinical research may enhance its market position and attract further investment.
AI Generated • Sep 22, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Daniel Carcillo

Website

www.wesanahealth.com

Headquarters

Chicago, IL 60607, US

WSNAF Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-506.80%

Return on Capital

N/A

Return on Assets

-176.71%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$73.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

20.92M

Volume

200

Avg. Volume

18.539

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$460.16K

EBITDA

-$567.22K

Operating Cash Flow

-$422.96K

Capital Expenditure

$1.00

Free Cash Flow

-$422.95K

Cash & ST Invst.

$46.93K

Total Debt

$250.00K

Wesana Health Performance Analysis

Wesana Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
Wesana Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31N/A
Q12024-03-31N/A
Q22024-06-30N/A
Q32024-09-30N/A
Wesana Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -1.48N/A
20222022-12-31USD -0.25-83.1%
20232023-12-31USD -0.05-80.3%
Wesana Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31-300.0%
Q12024-03-3182.8%
Q22024-06-308.2%
Q32024-09-3082.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$73.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$10.46K

N/A

Employees

7

N/A

Net Income

-$36.67K

-105.9%

EBITDA

-$33.06K

+96.4%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

$46.93K

-93.1%

Total Debt

$250.00K

+0.0%

Accounts Receivable

$50.92K

-94.6%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$250.00K

+0.0%

Return on Assets

-1.77%

N/A

Return on Invested Capital

4.13%

N/A

Free Cash Flow

-$16.68K

+93.2%

Operating Cash Flow

-$16.68K

+93.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LFCOFLift & Co. Corp.
$0.00+0.00%
IPIXInnovation Pharmaceuticals Inc.
$0.00+0.00%
NBIONascent Biotech, Inc.
$0.00+0.00%
RGRXRegeneRx Biopharmaceuticals, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$89.85-5.79%
NVDANvidia
$214.13-1.43%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$93.67-12.74%
CCCCCC Intelligent Solutions
$7.61-0.26%

Questions About WSNAF

What is the current price of Wesana Health?

Wesana Health is trading at $0.00 per share.

What is the 52-week range for Wesana Health?

Over the past 52 weeks, Wesana Health has traded between $0.00 and $0.03.

How much debt does Wesana Health have?

As of the most recent reporting period, Wesana Health reported total debt of $250.00K.

How much cash does Wesana Health have on hand?

Wesana Health reported $42.72K in cash and cash equivalents in its most recent financial results.

What is Wesana Health’s dividend yield?

Wesana Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services